proguanil has been researched along with Bladder Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, J; Hu, X; Peng, M; Wu, J; Xiao, D; Xu, S; Yang, X; Zhou, S | 1 |
| desBORDES, C; Kim, H; Lea, MA | 1 |
2 other study(ies) available for proguanil and Bladder Cancer
| Article | Year |
|---|---|
Inhibitory role of proguanil on the growth of bladder cancer via enhancing EGFR degradation and inhibiting its downstream signaling pathway to induce autophagy.
Topics: Autophagy; Carrier Proteins; Endocytosis; ErbB Receptors; Humans; Proguanil; Quality of Life; Signal Transduction; Urinary Bladder Neoplasms | 2022 |
Effects of Biguanides on Growth and Glycolysis of Bladder and Colon Cancer Cells.
Topics: Biguanides; Buformin; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Culture Media; Glucose; Glycolysis; HT29 Cells; Humans; Hydrogen-Ion Concentration; Hypoglycemic Agents; Mitochondria; Phenformin; Proguanil; Urinary Bladder Neoplasms | 2018 |